Literature DB >> 20055909

Dysplastic naevi: an update.

David E Elder1.   

Abstract

Dysplastic naevi are clinically atypical and histologically are characterized by architectural disorder and cytological atypia. Their diagnosis is reproducible if criteria and thresholds are agreed upon. They are significant only in relation to melanoma, as simulants of melanoma, as markers of individuals at increased risk of developing melanoma, and as potential and occasional actual precursors of melanoma. Morphologically and biologically, they are intermediate between common naevi and melanoma. Individuals with dysplastic naevi may have deficient DNA repair, and dysplastic naevi lesions are associated with overexpression of pheomelanin, which may lead to increased oxidative damage and increased potential for DNA damage and tumour progression.

Entities:  

Mesh:

Year:  2010        PMID: 20055909     DOI: 10.1111/j.1365-2559.2009.03450.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  18 in total

1.  Mammalian pigmentation is regulated by a distinct cAMP-dependent mechanism that controls melanosome pH.

Authors:  Dalee Zhou; Koji Ota; Charlee Nardin; Michelle Feldman; Adam Widman; Olivia Wind; Amanda Simon; Michael Reilly; Lonny R Levin; Jochen Buck; Kazumasa Wakamatsu; Shosuke Ito; Jonathan H Zippin
Journal:  Sci Signal       Date:  2018-11-06       Impact factor: 8.192

2.  Agminated acquired melanocytic nevi of the common and dysplastic type.

Authors:  Yoon Jung Choi; Hei Sung Kim; Jun Young Lee; Hyung Ok Kim; Young Min Park
Journal:  Ann Dermatol       Date:  2013-08-13       Impact factor: 1.444

Review 3.  Dysplastic nevi and melanoma.

Authors:  Alisa M Goldstein; Margaret A Tucker
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04       Impact factor: 4.254

4.  Novel immune signatures associated with dysplastic naevi and primary cutaneous melanoma in human skin.

Authors:  Bernice Y Yan; Sandra Garcet; Nicholas Gulati; Felix Kiecker; Judilyn Fuentes-Duculan; Patricia Gilleaudeau; Mary Sullivan-Whalen; Avner Shemer; Hiroshi Mitsui; James G Krueger
Journal:  Exp Dermatol       Date:  2018-12-21       Impact factor: 3.960

5.  Massively parallel sequencing analysis of benign melanocytic naevi.

Authors:  John R Lozada; Felipe C Geyer; Pier Selenica; David Brown; Barbara Alemar; Taha Merghoub; Michael F Berger; Klaus J Busam; Allan C Halpern; Britta Weigelt; Jorge S Reis-Filho; Travis J Hollmann
Journal:  Histopathology       Date:  2019-05-24       Impact factor: 5.087

Review 6.  [Dysplastic melanocytic nevus].

Authors:  E Bierhoff
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

7.  Obligate and Potential Precursors of Melanoma.

Authors:  David E Elder
Journal:  J Natl Cancer Inst       Date:  2022-10-06       Impact factor: 11.816

8.  Promoter CpG island hypermethylation in dysplastic nevus and melanoma: CLDN11 as an epigenetic biomarker for malignancy.

Authors:  Linda Gao; Karin van den Hurk; Peter T M Moerkerk; Jelle J Goeman; Samuel Beck; Nelleke A Gruis; Joost J van den Oord; Véronique J Winnepenninckx; Manon van Engeland; Remco van Doorn
Journal:  J Invest Dermatol       Date:  2014-07-07       Impact factor: 8.551

Review 9.  Glioblastoma and acute myeloid leukemia: malignancies with striking similarities.

Authors:  Eric Goethe; Bing Z Carter; Ganesh Rao; Naveen Pemmaraju
Journal:  J Neurooncol       Date:  2017-12-01       Impact factor: 4.130

10.  On the clinical significance of cutaneous melanoma's precursors.

Authors:  Giuseppe Noto
Journal:  Indian Dermatol Online J       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.